Clinical Trial Update: Serplulimab for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating serplulimab for locally advanced cervical cancer is ongoing and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Cervical Cancer | Phase 2 | Status: RECRUITING